Home › Valeant boosts offer for Salix Pharma to about $11.11B
 

Keywords :   


Valeant boosts offer for Salix Pharma to about $11.11B

2015-03-16 14:06:50| Biotech - Topix.net

Valeant is raising its offer for Salix Pharmaceuticals to about $11.11 billion, heating up a bidding fight for the company. The Canadian drug maker's new bid is for $173 per Salix share, a 2 percent premium over Friday closing price of $169.40.

Tags: offer pharma boosts salix

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.09Economy worries swirl after 'painful' Budget warning
20.09Atlantic Tropical Weather Outlook
20.09Eastern North Pacific Tropical Weather Outlook
20.09Would you let AI plan your next holiday?
20.09Nike boss steps down as company veteran returns
19.09MCC Paarl hosts 21st Annual Student Label Design Competition
19.09Certified Angus Beef awards 26 scholarships
19.09Food Safety and Fellowship
More »